(Q64996689)

3 July 2019

title

Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease. (English)

1 reference

3 July 2019

14

Henrik Zetterberg

1 reference

3 July 2019

11

Dennis J Selkoe

1 reference

3 July 2019

Robert A Rissman

4

object named as

Robert A Rissman

1 reference

3 July 2019

author name string

Zhicheng Chen

1

1 reference

3 July 2019

David Mengel

2

1 reference

3 July 2019

Ashvini Keshavan

3

1 reference

3 July 2019

Andrew Billinton

5

1 reference

3 July 2019

Michael Perkinton

6

1 reference

3 July 2019

Jennifer Percival-Alwyn

7

1 reference

3 July 2019

Aaron Schultz

8

1 reference

3 July 2019

Michael Properzi

9

1 reference

3 July 2019

Keith Johnson

10

1 reference

3 July 2019

Reisa A Sperling

12

1 reference

3 July 2019

Purvish Patel

13

1 reference

3 July 2019

Douglas Galasko

15

1 reference

3 July 2019

Jonathan M Schott

16

1 reference

3 July 2019

Dominic M Walsh

17

1 reference

3 July 2019

publication date

9 November 2018

1 reference

3 July 2019

published in

Alzheimer's and Dementia

1 reference

3 July 2019

volume

15

1 reference

3 July 2019

issue

3

1 reference

3 July 2019

page(s)

487-496

1 reference

3 July 2019

Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system

cites work

1 reference

12 December 2020

Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type

1 reference

12 December 2020

Distribution of Big tau in the central nervous system of the adult and developing rat

1 reference

12 December 2020

The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments

1 reference

12 December 2020

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

1 reference

12 December 2020

The Declaration of Helsinki

1 reference

12 December 2020

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

1 reference

12 December 2020

Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study

1 reference

12 December 2020

The ELISA-measured increase in cerebrospinal fluid tau that discriminates Alzheimer's disease from other neurodegenerative disorders is not attributable to differential recognition of tau assembly forms

1 reference

12 December 2020

Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma.

1 reference

12 December 2020

Plasma tau levels in Alzheimer's disease

1 reference

12 December 2020

Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease.

1 reference

12 December 2020

Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease

1 reference

12 December 2020

Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early Alzheimer's disease.

1 reference

12 December 2020

Biomarker modeling of Alzheimer's disease

1 reference

12 December 2020

Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy

1 reference

12 December 2020

Tau, s-100 calcium-binding protein B, and neuron-specific enolase as biomarkers of concussion-reply.

1 reference

12 December 2020

C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death.

1 reference

12 December 2020

Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques

1 reference

12 December 2020

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes

1 reference

12 December 2020

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

1 reference

12 December 2020

Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort.

1 reference

12 December 2020

Plasma tau in Alzheimer disease

1 reference

12 December 2020

Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy

1 reference

12 December 2020

Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease

1 reference

12 December 2020

Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging

1 reference

12 December 2020

Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort.

1 reference

12 December 2020

Increased levels of plasma total tau in adult Down syndrome.

1 reference

12 December 2020

Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles.

1 reference

12 December 2020

Tau Kinetics in Neurons and the Human Central Nervous System

1 reference

12 December 2020

10.1016/J.JALZ.2018.09.010

Identifiers

DOI

1 reference

3 July 2019

PMCID

6476313

1 reference

3 July 2019

PubMed ID

30419228

1 reference

3 July 2019